BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23396425)

  • 21. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
    Maisin D; Lepoutre T; Gruson D; Wallemacq P
    Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
    Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
    Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda.
    Velthuis HT; Knop I; Stam P; van den Broek M; Bos HK; Hol S; Teunissen E; Fischedick KS; Althaus H; Schmidt B; Wagner C; Melsert R
    Clin Chem Lab Med; 2011 Aug; 49(8):1323-1332. PubMed ID: 21663464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interlaboratory study of free monoclonal immunoglobulin light chain quantification.
    Vávrová J; Maisnar V; Tichý M; Friedecký B; Čermáková Z; Dastych M; Gottwaldová J; Kučera P; Krotká J; Racek J; Ženková J; Schneiderka P; Lochman P; Zima T; Benáková H; Büchler T; Spáčilová J; Hájek R; Palička V
    Clin Chem Lab Med; 2011 Jan; 49(1):89-92. PubMed ID: 21034251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots.
    Pretorius CJ; Klingberg S; Tate J; Wilgen U; Ungerer JP
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):450-5. PubMed ID: 22764186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation electrophoreses would detect.
    Shaheen SP; Levinson SS
    Clin Chim Acta; 2009 Aug; 406(1-2):162-6. PubMed ID: 19410572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Free light chains assay: Indications and methods].
    Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
    Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays.
    Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum-free light-chain assay: clinical utility and limitations.
    Bhole MV; Sadler R; Ramasamy K
    Ann Clin Biochem; 2014 Sep; 51(Pt 5):528-42. PubMed ID: 24489083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use.
    Hansen CT; Münster AM; Nielsen L; Pedersen P; Abildgaard N
    Eur J Haematol; 2012 Dec; 89(6):458-68. PubMed ID: 22998393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of measurement of free light chains].
    Matsuda M
    Rinsho Byori; 2010 Apr; 58(4):401-4. PubMed ID: 20496770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of free light chains--a new method of diagnostics of haematological diseases].
    Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
    Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
    Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
    Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
    Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
    Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
    J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
    Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
    Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
    Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
    Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers.
    Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB
    Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.